Literature DB >> 12045568

The effects of rapamycin in murine peripheral nerve isografts and allografts.

Terence M Myckatyn1, Ramsey A Ellis, Aaron G Grand, Subhro K Sen, James B Lowe, Daniel A Hunter, Susan E Mackinnon.   

Abstract

The FKBP-12-binding ligand FK506 has been successfully used to stimulate nerve regeneration and prevent the rejection of peripheral nerve allografts. The immunosuppressant rapamycin, another FKBP-12-binding ligand, stimulates axonal regeneration in vitro, but its influence on nerve regeneration in peripheral nerve isografts or allografts has not been studied. Sixty female inbred BALB/cJ mice were randomized into six tibial nerve transplant groups, including three isograft and three allograft (C57BL/6J) groups. Grafts were left untreated (groups I and II), treated with FK506 (groups III and IV), or treated with rapamycin (groups V and VI). Nerve regeneration was quantified in terms of histomorphometry and functional recovery, and immunosuppression was confirmed with mixed lymphocyte reactivity assays. Animals treated with FK506 and rapamycin were immunosuppressed and demonstrated significantly less immune cell proliferation relative to untreated recipient animals. Although every animal demonstrated some functional recovery during the study, animals receiving an untreated peripheral nerve allograft were slowest to recover. Isografts treated with FK506 but not rapamycin demonstrated significantly increased nerve regeneration. Nerve allografts in animals treated with FK506, and to a lesser extent rapamycin, however, both demonstrated significantly more nerve regeneration and increased nerve fiber widths relative to untreated controls. The authors suggest that rapamycin can facilitate regeneration through peripheral nerve allografts, but it is not a neuroregenerative agent in this in vivo model. Nerve regeneration in FK506-treated peripheral nerve isografts and allografts was superior to that found in rapamycin-treated animals. Rapamycin may have a role in the treatment of peripheral nerve allografts when used in combination with other medications, or in the setting of renal failure that often precludes the use of calcineurin inhibitors such as FK506.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12045568     DOI: 10.1097/00006534-200206000-00035

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  8 in total

1.  The effects of cold preservation and subimmunosuppressive doses of FK506 on axonal regeneration in murine peripheral nerve isografts.

Authors:  Terence M Myckatyn; Daniel A Hunter; Susan E Mackinnon
Journal:  Can J Plast Surg       Date:  2003

2.  Effect of Tacrolimus and Cyclosporine Immunosuppressants on Peripheral Nerve Regeneration: Systematic Review and Meta-analysis.

Authors:  Stéphanie Farias Seixas; Gabriele Carra Forte; Gabriela Agne Magnus; Valentina Stanham; Rita Mattiello; Jefferson Braga Silva
Journal:  Rev Bras Ortop (Sao Paulo)       Date:  2022-05-27

3.  Treatment modality affects allograft-derived Schwann cell phenotype and myelinating capacity.

Authors:  Ayato Hayashi; Arash Moradzadeh; Alice Tong; Cindy Wei; Sami H Tuffaha; Daniel A Hunter; Thomas H Tung; Alexander Parsadanian; Susan E Mackinnon; Terence M Myckatyn
Journal:  Exp Neurol       Date:  2008-04-25       Impact factor: 5.330

4.  Tacrolimus (FK506): Safety and Applications in Reconstructive Surgery.

Authors:  Thomas H Tung
Journal:  Hand (N Y)       Date:  2009-04-11

5.  CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy.

Authors:  Yunqi Zhao; Ti Zhang; Shaofeng Duan; Neal M Davies; M Laird Forrest
Journal:  Nanomedicine       Date:  2014-03-15       Impact factor: 5.307

6.  Profiling circulating microRNA expression in a mouse model of nerve allotransplantation.

Authors:  Cheng-Shyuan Rau; Johnson Chia-Shen Yang; Shao-Chun Wu; Yi-Chun Chen; Tsu-Hsiang Lu; Ming-Wei Lin; Yi-Chan Wu; Siou-Ling Tzeng; Chia-Jung Wu; Ching-Hua Hsieh
Journal:  J Biomed Sci       Date:  2013-09-05       Impact factor: 8.410

7.  mTORC1 is essential for early steps during Schwann cell differentiation of amniotic fluid stem cells and regulates lipogenic gene expression.

Authors:  Andrea Preitschopf; Kongzhao Li; David Schörghofer; Katharina Kinslechner; Birgit Schütz; Ha Thi Thanh Pham; Margit Rosner; Gabor Jozsef Joo; Clemens Röhrl; Thomas Weichhart; Herbert Stangl; Gert Lubec; Markus Hengstschläger; Mario Mikula
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

8.  Rapamycin promotes Schwann cell migration and nerve growth factor secretion.

Authors:  Fang Liu; Haiwei Zhang; Kaiming Zhang; Xinyu Wang; Shipu Li; Yixia Yin
Journal:  Neural Regen Res       Date:  2014-03-15       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.